FDA-Cleared Molecular Test Targets Growing US Cyclospora Outbreak
QIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.
Read More
Search Results for: liver disease
Researchers Develop Electronic Genome Mapping Assay for FSHD Diagnosis
Nabsys and Leiden University Medical Center are collaborating to evaluate an electronic genome mapping assay for improved detection of FSHD-associated repeat contractions, aiming to address current diagnostic limitations.
Read More
Study Supports Multi-Omic Blood Test Strategy for Ovarian Cancer Detection
Researchers identified coordinated lipid, metabolite, and protein signatures in symptomatic patients, supporting a multi-omic strategy for earlier ovarian cancer detection.
Read More
Anthem to Cover Quanterix’s LucentAD Complete Alzheimer’s Blood Test
The insurer will provide coverage for the multi-analyte test starting July 2026, following new data showing parity with mass spectrometry.
Read More
Labcorp Expands Access to Non-Invasive MASH Blood Test Through Online Platform
The NASHnext assay, powered by GENFIT’s NIS4 technology, is designed to identify patients with at-risk MASH through a blood draw ordered via the Labcorp OnDemand platform.
Read More